Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Rocco

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Immunology|May 2, 2024
Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patientsAinhoa Pérez-Díez, Xiangdong Liu, Stephanie Calderon, et al.
The Journal of Infectious Diseases|January 20, 2026
Inflammasome activation and oxidative stress in SARS-CoV-2 infection and symptomatic reboundSilvia Lucena Lage, Joseph M Rocco, Cihan Oguz, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
Persistent immune dysregulation and metabolic alterations following SARS-CoV-2 infectionSilvia Lucena Lage, Katherine Bricker-Holt, Joseph M Rocco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2022
Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir TreatmentBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavirBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
The New England Journal of Medicine|March 20, 2024
Anti-Interleukin-23 Autoantibodies in Adult-Onset ImmunodeficiencyAristine Cheng, Anuj Kashyap, Helene Salvator, et al.
Journal for Immunotherapy of Cancer|June 5, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial resultsSara K Silbert, Flavia Gava, Bonnie Yates, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Immunology|May 2, 2024
Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patientsAinhoa Pérez-Díez, Xiangdong Liu, Stephanie Calderon, et al.
The Journal of Infectious Diseases|January 20, 2026
Inflammasome activation and oxidative stress in SARS-CoV-2 infection and symptomatic reboundSilvia Lucena Lage, Joseph M Rocco, Cihan Oguz, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
Persistent immune dysregulation and metabolic alterations following SARS-CoV-2 infectionSilvia Lucena Lage, Katherine Bricker-Holt, Joseph M Rocco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2022
Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir TreatmentBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavirBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
The New England Journal of Medicine|March 20, 2024
Anti-Interleukin-23 Autoantibodies in Adult-Onset ImmunodeficiencyAristine Cheng, Anuj Kashyap, Helene Salvator, et al.
Journal for Immunotherapy of Cancer|June 5, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial resultsSara K Silbert, Flavia Gava, Bonnie Yates, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Pageof 3